Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	74
Overall Study	STARTED	Setipiprant	83
Overall Study	STARTED	Finasteride	12
Overall Study	Safety Population (Treated)	Placebo	73
Overall Study	Safety Population (Treated)	Setipiprant	81
Overall Study	Safety Population (Treated)	Finasteride	12
Overall Study	mITT Population	Placebo	70
Overall Study	mITT Population	Setipiprant	78
Overall Study	mITT Population	Finasteride	11
Overall Study	COMPLETED	Placebo	48
Overall Study	COMPLETED	Setipiprant	57
Overall Study	COMPLETED	Finasteride	8
Overall Study	NOT COMPLETED	Placebo	26
Overall Study	NOT COMPLETED	Setipiprant	26
Overall Study	NOT COMPLETED	Finasteride	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02781311/flow